We will include clinical studies (including randomised controlled trials (RCTs) and observational studies) that assess effectiveness and safety of the 6 SGLT2 inhibitors, considering that adverse events were assessed in longer term observational studies,26, 27 especially events of cardiovascular disease, ketoacidosis and cancer. Here, SLC5A2 is linked to cardiovascular disorder.